Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Hepatitis C virus in Arab world: a state of concern.

Daw MA, Dau AA.

ScientificWorldJournal. 2012;2012:719494. doi: 10.1100/2012/719494. Epub 2012 May 2. Review.

2.

Hepatitis B and C virus infections among pregnant women in Arab and African countries.

Gasim GI, Murad IA, Adam I.

J Infect Dev Ctries. 2013 Aug 15;7(8):566-78. doi: 10.3855/jidc.3243. Review.

3.

Comment on: "hepatitis C virus in Arab world: a state of concern".

Gasim GI.

ScientificWorldJournal. 2012;2012:534173. doi: 10.1100/2012/534173. Epub 2012 Sep 27. No abstract available.

4.

Epidemiology of hepatitis C in the Middle East.

Fallahian F, Najafi A.

Saudi J Kidney Dis Transpl. 2011 Jan;22(1):1-9. Review.

5.

Distribution of hepatitis C virus genotypes in the Middle East.

Ramia S, Eid-Fares J.

Int J Infect Dis. 2006 Jul;10(4):272-7. Epub 2006 Mar 27. Review.

6.

Hepatitis B virus in the Arab world: where do we stand?

Gasim GI.

Arab J Gastroenterol. 2013 Jun;14(2):35-43. doi: 10.1016/j.ajg.2013.04.002. Epub 2013 May 17. Review.

PMID:
23820498
7.

Surveillance and epidemiology of hepatitis B and C in Europe - a review.

Rantala M, van de Laar MJ.

Euro Surveill. 2008 May 22;13(21). pii: 18880. Review.

8.

Acute hepatitis C virus infection.

Irving WL, Salmon D, Boucher C, Hoepelman IM.

Euro Surveill. 2008 May 22;13(21). pii: 18879.

9.

High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies.

Huraib S, al-Rashed R, Aldrees A, Aljefry M, Arif M, al-Faleh FA.

Nephrol Dial Transplant. 1995;10(4):470-4.

PMID:
7623989
11.

Global burden of hepatitis C: considerations for healthcare providers in the United States.

Averhoff FM, Glass N, Holtzman D.

Clin Infect Dis. 2012 Jul;55 Suppl 1:S10-5. doi: 10.1093/cid/cis361.

PMID:
22715208
12.

Epidemiology of hepatitis C infection and its public health implications in Puerto Rico.

Pérez CM, Suárez E, Torres EA.

P R Health Sci J. 2004 Jun;23(2 Suppl):11-28. Review.

PMID:
16929583
13.

Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection--sub-Saharan Africa, 2000-2011.

Apata IW, Averhoff F, Pitman J, Bjork A, Yu J, Amin NA, Dhingra N, Kolwaite A, Marfin A; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):613-9.

14.

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L.

Lancet. 2011 Aug 13;378(9791):571-83. doi: 10.1016/S0140-6736(11)61097-0. Epub 2011 Jul 27. Review.

15.

Evolving epidemiology of hepatitis C virus.

Lavanchy D.

Clin Microbiol Infect. 2011 Feb;17(2):107-15. doi: 10.1111/j.1469-0691.2010.03432.x. Review.

16.

Global epidemiology and genotype distribution of the hepatitis C virus infection.

Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H.

J Hepatol. 2014 Nov;61(1 Suppl):S45-57. doi: 10.1016/j.jhep.2014.07.027. Epub 2014 Jul 30. Review.

17.

Epidemiology of HCV infection in Latin America.

Méndez-Sánchez N, Gutiérrez-Grobe Y, Kobashi-Margáin RA.

Ann Hepatol. 2010;9 Suppl:27-9.

PMID:
20713991
18.

The importance of preventing hepatitis C virus infection among injection drug users in the United States.

Alter MJ, Moyer LA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S6-10.

PMID:
9663617
19.

The state of health in the Arab world, 1990-2010: an analysis of the burden of diseases, injuries, and risk factors.

Mokdad AH, Jaber S, Aziz MI, AlBuhairan F, AlGhaithi A, AlHamad NM, Al-Hooti SN, Al-Jasari A, AlMazroa MA, AlQasmi AM, Alsowaidi S, Asad M, Atkinson C, Badawi A, Bakfalouni T, Barkia A, Biryukov S, El Bcheraoui C, Daoud F, Forouzanfar MH, Gonzalez-Medina D, Hamadeh RR, Hsairi M, Hussein SS, Karam N, Khalifa SE, Khoja TA, Lami F, Leach-Kemon K, Memish ZA, Mokdad AA, Naghavi M, Nasher J, Qasem MB, Shuaib M, Al Thani AA, Al Thani MH, Zamakhshary M, Lopez AD, Murray CJ.

Lancet. 2014 Jan 25;383(9914):309-20. doi: 10.1016/S0140-6736(13)62189-3. Epub 2014 Jan 20.

PMID:
24452042
20.

Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at kidney centre in a tertiary health facility in Maiduguri, Nigeria.

Ummate I, Denue BA, Kida IM, Ohioma OJ, Baba DB, Goni W.

Pan Afr Med J. 2014 Nov 21;19:305. doi: 10.11604/pamj.2014.19.305.5639. eCollection 2014.

Supplemental Content

Support Center